Industry Notes

Industry Notes / Pharma / Chapter 7 of 20 · Pie

Global peak sales: the US takes more than half

The ceiling is set by payers, not by science

What is still unclear?

Write what you still want explained. Questions go to the author and are not shown publicly.

Share of global peak sales
  • US58% · 66%
  • EU518% · 20%
  • Japan7% · 8%
  • China5% · 6%

In an illustrative split, peak sales are about 50%–65% in the US, 15%–20% in the EU5, 5%–8% in Japan, and 3%–8% in China. The chart uses midpoints: 58 / 18 / 7 / 5. Being number one at home still captures only a thin slice of global value.

Source:创新药峰值销售地理拆分的行业示意口径(美约 50%–65%);非单一机构普查,须按品种核实

Research notes, not investment advice.